The inhibition of IDO could trigger the induction of the co-expressed TDO as a compensatory immunosuppressive mechanism and, therefore, IDO inhibition alone will likely not suffice to prevent kynurenine-mediated immunosuppression in most cancers. Here, IDO1 is linked to cancer.